9-ME-BC_Dosage, benefits & legal status
Also known as 9-methyl-beta-carboline, 9-Me-BC, 9MBC
A beta-carboline sold as a brain booster, with real lab effects on dopamine cells and no human trials at all.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is 9-ME-BC?
Plain language first. The technical label stays, but it never stands alone.Overview
Lab studies suggest it can raise dopamine and protect dopamine brain cells, but it has never been studied in a single human.
9-ME-BC (9-methyl-beta-carboline) is a synthetic beta-carboline with dopaminergic and neuroprotective effects in preclinical models.
What it's used for
Marketed for focus, drive and general cognitive support, based entirely on cell and animal findings.
How does 9-ME-BC work?
What it does in the body, and where.A small synthetic molecule from the beta-carboline family that, in lab studies, changes how dopamine cells behave.
- 01Raises dopamine in the labIn cell and animal work it can increase dopamine synthesis and release.
- 02Protects dopamine neurons in modelsSome studies show reduced loss of dopamine-producing cells under toxic stress.
- 03The family has a dark sideBeta-carbolines can also be neurotoxic at higher exposures, and which effect dominates at which dose has never been tested in humans.

What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Dopamine-cell protection in cell and animal models, the finding that fuels the marketingResearch only
- Focus and drive in community use, never tested in humansResearch only
The published record
Papers and trials about 9-ME-BC
Searched: 9-methyl-beta-carboline, 9-methyl-β-carboline, 9-Me-BC, 9-methyl-9H-beta-carboline.
3 papers tagged human · 1 not reviews or lab · 0 clinical trial publications
Furthest stage reached: No clinical trial on record
Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

At a glance
Four things to know about 9-ME-BC
How much, and do you cycle it?
The range, and whether you take breaks.10 up to 20 mg per day, daily. Cycled in courses in community use, typically a few weeks on then off Community practice
No study of any kind informs cycling. Community practice borrows a cautious on-off pattern from other nootropics.
Not establishedCommunity practice
Pharmacokinetics have never been characterized in humans.
Not yet traced to a primary source.
You can compare this against the whole library to see where it sits.
What does it cost?
Typical dose and cost, in plain numbers.The products priced here are not injected
Route: swallowed (oral), in community use.
9-ME-BC starts at $36.00 across 10 vendors.
10 listings, last read Oct 24, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized 9-ME-BC keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.Who should avoid it
- No formal contraindications established
- Pregnancy
- Anyone taking medicines that affect dopamine, as an interaction has never been ruled out
Stop and get help
- No human use has been studied, so there is no documented adverse-event profile to reference
- Signs of an allergic reaction
Common effects
- Reports come from community use only: some users describe sharper focus or drive, others nothing at all
- Headache and insomnia are the most commonly mentioned complaints in user reports
- Nothing about frequency or severity is documented in any controlled setting
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is 9-ME-BC approved?
And where the numbers on this page come from.No. 9-ME-BC is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.
- Approval statusResearch only
- RouteSwallowed (oral), in community use
- Checked12 September 2026
- DoseFrom community reports. No regulator or trial established this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
What has happened recently
We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.
You can compare this against the whole library, or read how to check a seller.
What else is like 9-ME-BC?
Others in Brain, mood and sleep, side by side.If you're weighing 9-ME-BC, it's worth reading Adamax 984, CMS-121, and Dermorphin in the same class.
A beta-carboline sold as a brain booster, with real lab effects on dopamine cells and no human trials at all.
- Dose
- 10 up to 20 mg per day
- How often
- Daily
A second molecule sold as Adamax: acetylated Semax with two amino acids added and no adamantane.
- Dose
- Research only
- How often
- No established schedule
A fisetin derivative from Salk, in humans since 2022 with no results published.
- Dose
- No established human dose
- How often
- No established schedule
A frog-skin opioid many times stronger than morphine, best known from horse racing scandals.
- Dose
- Research only
- How often
- Varies
Guides for this compound
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
- How to Vet a Peptide Vendor
Independent COAs, HPLC purity, and the red flags that mean walk away.
Sources
- FDA, bulk drug substances nominated for use in compounding under section 503A, updated 14 May 2026(2026)This compound appears in none of the three categories on this list, which is the comprehensive record of what has been proposed for pharmacy compounding since the process opened in 2013, so absence from all three categories means no one has ever put this compound forward.
Beyond these, 10 records are indexed. Browse the records
